Quantitative Investment Management LLC Invests $1.83 Million in Celestica, Inc. $CLS
Quantitative Investment Management LLC has invested $1.83 million in Celestica, Inc. (NYSE: CLS) by acquiring 23,208 shares in the first quarter. Other hedge funds have also increased their stakes in Celestica, with significant boosts from Jump Financial LLC and British Columbia Investment Management Corp. Celestica's stock has risen 30%, and analysts have set new price targets, with a consensus rating of "Buy" and a target price of $168.92. The company reported strong quarterly earnings, exceeding estimates with a revenue of $2.89 billion and a net margin of 5.11%.
Quantitative Investment Management LLC purchased a new position in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 23,208 shares of the technology company's stock, valued at approximately $1,829,000.
- This mid-cap tech stock just jumped 30%...and is still cheap
A number of other hedge funds have also made changes to their positions in CLS. Jump Financial LLC boosted its position in shares of Celestica by 128.9% during the first quarter. Jump Financial LLC now owns 60,625 shares of the technology company's stock worth $4,778,000 after buying an additional 34,138 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its holdings in Celestica by 640.3% during the 1st quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 475,439 shares of the technology company's stock worth $37,511,000 after buying an additional 411,213 shares during the last quarter. Cunning Capital Partners LP purchased a new stake in shares of Celestica in the 1st quarter valued at about $4,111,000. Kestra Advisory Services LLC lifted its holdings in shares of Celestica by 19.3% in the 1st quarter. Kestra Advisory Services LLC now owns 18,571 shares of the technology company's stock valued at $1,464,000 after purchasing an additional 3,005 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in Celestica by 78.1% during the 1st quarter. Ameriprise Financial Inc. now owns 710,723 shares of the technology company's stock valued at $56,012,000 after acquiring an additional 311,646 shares during the last quarter. Institutional investors and hedge funds own 67.38% of the company's stock.
Celestica Trading Up 4.4%
Shares of NYSE:CLS opened at $189.2390 on Monday. The company has a current ratio of 1.44, a quick ratio of 0.86 and a debt-to-equity ratio of 0.48. Celestica, Inc. has a 1 year low of $40.65 and a 1 year high of $218.80. The firm has a fifty day moving average price of $170.54 and a 200 day moving average price of $125.07. The stock has a market capitalization of $21.77 billion, a PE ratio of 40.96 and a beta of 1.80.
- 3 bullish mid-cap earnings plays for January 2024
Celestica (NYSE:CLS - Get Free Report) TSE: CLS last released its quarterly earnings data on Monday, July 28th. The technology company reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.16. The company had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.65 billion. Celestica had a net margin of 5.11% and a return on equity of 28.23%. Celestica's revenue for the quarter was up 21.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 EPS. Celestica has set its Q3 2025 guidance at 1.370-1.530 EPS. FY 2025 guidance at 5.500-5.500 EPS. Analysts expect that Celestica, Inc. will post 4.35 EPS for the current fiscal year.
Analysts Set New Price Targets
Several research analysts recently weighed in on CLS shares. BMO Capital Markets reaffirmed an "outperform" rating and issued a $130.00 target price (up from $118.00) on shares of Celestica in a research report on Thursday, May 22nd. JPMorgan Chase & Co. boosted their target price on shares of Celestica from $170.00 to $225.00 and gave the company an "overweight" rating in a research note on Wednesday, July 30th. Barclays upped their price target on shares of Celestica from $146.00 to $220.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 30th. Citigroup upped their price target on shares of Celestica from $172.00 to $212.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 30th. Finally, Argus dropped their price target on shares of Celestica from $150.00 to $120.00 and set a "buy" rating on the stock in a research note on Tuesday, April 29th. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $168.92.
- 5 Cheap Ways to Ride The AI Supercycle to Profits
View Our Latest Analysis on Celestica
Celestica Company Profile
(Free Report)Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
Read More
- Five stocks we like better than Celestica
- What is the MACD Indicator and How to Use it in Your Trading
- Costco and Ross: 2 Ways to Play the Consumer Divide
- Profitably Trade Stocks at 52-Week Highs
- Is Paramount Skydance a Buy Post-Merger, Short Squeeze?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- V2X Stock: Defense Underdog Riding a $4.3B Air Force Contract
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Celestica Right Now?
Before you consider Celestica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celestica wasn't on the list.
While Celestica currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
